Physalins
Latest Information Update: 18 Nov 2003
At a glance
- Originator National Taiwan University
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Leukaemia
Most Recent Events
- 18 Nov 2003 Discontinued for Leukaemia (unspecified route)
- 20 Jun 2001 No-Development-Reported for Leukaemia (Unknown route)